drugset / Trial / NCT07618845

A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults

NCT07618845 ↗

Phase 1 Not yet recruiting 24 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults

Timeline

Start
2026-05
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-230 Unknown — Oral

Indications